Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Pathol Lab Med ; 122(3): 266-72, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9823867

ABSTRACT

BACKGROUND: Tumors of the pancreas with osteoclast-like giant cells are of uncertain histogenesis and aggressiveness. Their relationship, if any, to undifferentiated (anaplastic) carcinomas of the pancreas with pleomorphic giant cells is also not clear. METHODS: Eleven tumors with osteoclast-like giant cells were studied by immunohistochemistry for epithelial and mesenchymal markers, as well as for a proliferation marker (Ki67) and p53 protein expression. Cytometric image analysis for nuclear DNA content was also performed. K-ras mutations were investigated by DNA sequence analysis. RESULTS: Neoplastic, predominantly spindle-shaped cells and osteoclast-like giant cells were positive for mesenchymal markers CD68, LCA, and A1ACT. These spindle-shaped cells were also positive for human muscle actin. Spindle-shaped cells of seven tumors were also positive for epithelial markers carcinoembryonic antigen, epithelial membrane antigen, or keratin. Nine tumors contained a variable number of pleomorphic giant cells in addition to osteoclast-like giant cells. Pleomorphic giant cells were much less positive for mesenchymal markers than were osteoclast-like giant cells, but they were positive for some epithelial markers. A high percentage of spindle-shaped and pleomorphic giant cells were positive for Ki67. Diploid and aneuploid populations were present in varying proportions in both spindle cells and pleomorphic giant cells. The nuclei of osteoclast-like giant cells, however, were diploid and not proliferating. Spindle-shaped and pleomorphic giant cells were positive for p53 protein in 5 of 10 cases. Five of six tumors studied were positive for K-ras mutations. CONCLUSION: The distinction between tumors with osteoclast-like giant cells and undifferentiated carcinomas with pleomorphic giant cells is often not clear-cut. Both types of tumors have mesenchymal and epithelial characteristics in varying proportions and may arise from an undifferentiated pancreatic stem cell. Long-term survival of two patients suggests that some tumors with osteoclast-like giant cells may have a better prognosis than the usual pancreatic ductal adenocarcinoma.


Subject(s)
Giant Cells/pathology , Osteoclasts/pathology , Pancreatic Neoplasms/pathology , Cell Division/physiology , Genes, ras/genetics , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Mutation/genetics , Pancreatic Neoplasms/chemistry , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/immunology , Ploidies , Tumor Suppressor Protein p53/analysis
3.
Ann Plast Surg ; 36(3): 297-303, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8659955

ABSTRACT

Various centers report irradiated cartilage graft absorption rates that differ quite widely. We postulated that a major factor governing this phenomenon might be irradiation dose. Irradiation produces collagen cross-binding and increased resistance to absorption of such material when implanted. Since cross-binding produces stiffening of collagen, cartilage grafts were exposed to increasing doses of irradiation and their elastic modulus was measured. The postulate was that increasing radiation doses will produce grafts of increasing stiffness. Sternal cartilage, harvested from horses, was cut into blocks of a standard size and irradiated to 4, 6, 8, and 10 megarads. The elastic modulus of each specimen and matched control were measured on an Instron flexural testing machine (Instron Corp, Canton, MA). Irradiation at all four doses reduced the elastic modulus of the cartilage grafts, with the lowest dose producing a reduction of 50% and the highest dose one of 90%. High-dose irradiation appears to lessen greatly the stiffness of cartilage grafts and may be responsible for increasing absorption of grafts in centers in which high doses are used.


Subject(s)
Cartilage/radiation effects , Radiation Injuries, Experimental/pathology , Absorption , Animals , Cartilage/pathology , Cartilage/transplantation , Dose-Response Relationship, Radiation , Elasticity , Horses
4.
Urology ; 43(2): 203-8, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8116116

ABSTRACT

OBJECTIVE: To determine the efficacy of the vaginal wall sling in the management of recurrent stress urinary incontinence (SUI) in an elderly female population. METHOD: Eighteen elderly female patients (average age 68.4 years) with recurrent stress urinary incontinence were studied with a thorough evaluation including video-urodynamics. Thirteen patients were diagnosed with type III SUI and 5 patients had type II SUI: A description of the technique, first described by Raz, is provided. RESULTS: Follow-up ranged from six to forty-two months (average 18 months). All patients are completely dry and express satisfaction with their outcome. Seventeen of 18 patients (94%) are voiding spontaneously. One patient at twelve months' postoperation requires clean intermittent catheterization. CONCLUSION: Many elderly female patients with recurrent stress urinary incontinence have intrinsic urethral sphincteric incompetence as well as recurrent hypermobility that often classifies them as type II SUI: The vaginal wall sling addresses both problems and is a safe, simple, and effective procedure in the management of recurrent incontinence in elderly female patients.


Subject(s)
Urinary Incontinence, Stress/surgery , Vagina/surgery , Aged , Female , Follow-Up Studies , Humans , Patient Satisfaction , Recurrence , Suture Techniques , Time Factors , Urethra/physiopathology , Urinary Catheterization , Urinary Incontinence, Stress/epidemiology , Urinary Incontinence, Stress/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...